Tt International Asset Management LTD Denali Therapeutics Inc. Transaction History
Tt International Asset Management LTD
- $474 Million
- Q4 2025
A detailed history of Tt International Asset Management LTD transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Tt International Asset Management LTD holds 27,000 shares of DNLI stock, worth $470,880. This represents 0.07% of its overall portfolio holdings.
Number of Shares
27,000
Previous 65,000
58.46%
Holding current value
$470,880
Previous $943,000
62.57%
% of portfolio
0.07%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding DNLI
# of Institutions
263Shares Held
134MCall Options Held
219KPut Options Held
107K-
Black Rock Inc. New York, NY13.2MShares$230 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$215 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$209 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.64MShares$98.3 Million0.05% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL5.47MShares$95.3 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.34B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...